SCHEMBL692145

SCHEMBL692145

O=C1C=NNC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269174 0.65
SCHEMBL7447408 0.62
SCHEMBL363991 0.62
SCHEMBL3630407 0.60
SCHEMBL2598094 0.60
Hydrochloric Acid SCHEMBL18398546 0.60
SCHEMBL15956217 0.57
SCHEMBL19411844 0.57
SCHEMBL775375 0.57
Hydrochloric Acid SCHEMBL19207995 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2853534-A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use of same as antibacterial drugs ASTRA ZENECA HOLDING FRANCE (FR) 2015-04-01 EP claimed
WO-2010041108-A1 NITROGENOUS HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF, AND USE THEREOF AS ANTIBACTERIAL AGENTS NOVEXEL (FR) 2010-04-15 WO claimed
EP-1931672-A1 NOVEL 5,6-DIHYDROPYRAZOLO[3,4-E] [L,4]DIAZEPIN-4 (IH) -ONE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. AstraZeneca AB (SE) 2008-06-18 EP claimed
WO-2007040435-A1 NOVEL 5,6-DIHYDROPYRAZOLO[3,4-E] [L,4]DIAZEPIN-4 (IH) -ONE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. ASTRAZENECA AB (SE) 2007-04-12 WO claimed
EP-4289845-A1 TRIHETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Apeiron Therapeutics Company Limited (CN) 2023-12-13 EP disclosed
WO-2022223022-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL APPLICATION THEREOF 四川海思科制药有限公司 2022-10-27 WO disclosed
EP-2853534-A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use of same as antibacterial drugs ASTRA ZENECA HOLDING FRANCE (FR) 2015-04-01 EP disclosed
EP-2845855-A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use of same as antibacterial drugs ASTRA ZENECA HOLDING FRANCE (FR) 2015-03-11 EP disclosed
EP-2421870-A2 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF Abbott Laboratories (US) 2012-02-29 EP disclosed
EP-2358722-A1 NITROGENOUS HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF, AND USE THEREOF AS ANTIBACTERIAL AGENTS NOVEXEL (FR) 2011-08-24 EP disclosed
WO-2010124042-A2 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-10-28 WO disclosed
WO-2010041108-A1 NITROGENOUS HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF, AND USE THEREOF AS ANTIBACTERIAL AGENTS NOVEXEL (FR) 2010-04-15 WO disclosed
WO-2010038115-A1 NOVEL NITROGENOUS HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND USE THEREOF AS ANTIBACTERIAL MEDICAMENTS NOVEXEL (FR) 2010-04-08 WO disclosed
EP-1931672-A1 NOVEL 5,6-DIHYDROPYRAZOLO[3,4-E] [L,4]DIAZEPIN-4 (IH) -ONE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. AstraZeneca AB (SE) 2008-06-18 EP disclosed
WO-2007040435-A1 NOVEL 5,6-DIHYDROPYRAZOLO[3,4-E] [L,4]DIAZEPIN-4 (IH) -ONE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. ASTRAZENECA AB (SE) 2007-04-12 WO disclosed
EP-0288201-A1 Process for the preparation of benzodiazepines A.H. ROBINS COMPANY, INCORPORATED (US) 1988-10-26 EP disclosed